Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Translational Lung Cancer Research
|
June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.
British Journal of Cancer
|
June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
Jan Budczies, Eva Romanovsky, Martina Kirchner, et al.
Genes, Chromosomes & Cancer
|
February 28, 2023
Real-world data for precision cancer medicine-A European perspective
Petros Christopoulos, Richard Schlenk, Daniel Kazdal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes
Clemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
Cold Spring Harbor Molecular Case Studies
|
January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report
Markus Ball, Petros Christopoulos, Martina Kirchner, et al.
Frontiers in Oncology
|
April 26, 2021
<i>De Novo</i> Versus Secondary Metastatic <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer
Farastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study
Gabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
The Journal of Molecular Diagnostics : JMD
|
March 24, 2024
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
Markus Ball, Iordanis Ourailidis, Klaus Kluck, et al.
International Journal of Cancer
|
January 24, 2020
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
Tilmann Bochtler, Anna Reiling, Volker Endris, et al.
Genes, Chromosomes & Cancer
|
March 27, 2020
Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing
Suranand B Talla, Eugen Rempel, Volker Endris, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Translational Lung Cancer Research
|
June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.
British Journal of Cancer
|
June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
Jan Budczies, Eva Romanovsky, Martina Kirchner, et al.
Genes, Chromosomes & Cancer
|
February 28, 2023
Real-world data for precision cancer medicine-A European perspective
Petros Christopoulos, Richard Schlenk, Daniel Kazdal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2019
Patients Resistant Against PSMA-Targeting α-Radiation Therapy Often Harbor Mutations in DNA Damage-Repair-Associated Genes
Clemens Kratochwil, Frederik L Giesel, Claus-Peter Heussel, et al.
Cold Spring Harbor Molecular Case Studies
|
January 21, 2022
Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report
Markus Ball, Petros Christopoulos, Martina Kirchner, et al.
Frontiers in Oncology
|
April 26, 2021
<i>De Novo</i> Versus Secondary Metastatic <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer
Farastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study
Gabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
The Journal of Molecular Diagnostics : JMD
|
March 24, 2024
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
Markus Ball, Iordanis Ourailidis, Klaus Kluck, et al.
International Journal of Cancer
|
January 24, 2020
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
Tilmann Bochtler, Anna Reiling, Volker Endris, et al.
Genes, Chromosomes & Cancer
|
March 27, 2020
Immuno-oncology gene expression profiling of formalin-fixed and paraffin-embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing
Suranand B Talla, Eugen Rempel, Volker Endris, et al.
Page
of 12